Novel Therapeutic Targets for Glaucoma: Disease Modification Treatment, Neuroprotection, and Neuroregeneration
Authors:
- 11 April 2019
- book chapter
- Published by Springer Nature
- p. 147-176
Abstract
No abstract availableKeywords
This publication has 203 references indexed in Scilit:
- 17β-Estradiol Impedes Bax-Involved Mitochondrial Apoptosis of Retinal Nerve Cells Induced by Oxidative Damage via the Phosphatidylinositol 3-Kinase/Akt Signal PathwayJournal of Molecular Neuroscience, 2013
- Nutrient intake and risk of open-angle glaucoma: the Rotterdam StudyEuropean Journal of Epidemiology, 2012
- Targeting p38 MAPK pathway for the treatment of Alzheimer's diseaseNeuropharmacology, 2010
- Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptorsCell Death & Disease, 2010
- SOCS3 Deletion Promotes Optic Nerve Regeneration In VivoNeuron, 2009
- Gene expression profiling of TGFβ2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-β2 signalingExperimental Eye Research, 2009
- Minocycline and neurodegenerative diseasesBehavioural Brain Research, 2009
- Mitochondrial Medicine for Aging and Neurodegenerative DiseasesNeuroMolecular Medicine, 2008
- AT1receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen‐induced retinopathyGlia, 2008
- Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequencesProgress in Retinal and Eye Research, 2006